NASDAQ:ALLR

Allarity Therapeutics Stock Insider Trading

etoro logo Buy ALLR
*Your capital is at risk
$1.58
-0.110 (-6.51%)
At Close: Jun 03, 2026

Allarity Therapeutics Stock Insider Power

Based on the 47 latest insides trades, we have calculated the insider power to be positive at 95.69. In total, the insiders bought 3.38M and sold 29.23K ALLR shares in the last 47 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 47 transactions)
95.69
Buy 3.38M shares
Sell 29.23K shares
96% Buy Activity
Strong Negative Correlation
Buy Signal High Confidence
Jan 28, 2026

Analysis Breakdown:

  • Strongly supported by a very high Insider Power Score of 95.69.
  • Confidence increased due to high data reliability score of 90.
  • Supported by overwhelming buy-side pressure (96% buys).

Historical Insider Trades

Date Type Person Role Amount
Jan 22, 2025
Buy
Common Stock
A-Award
Epshinsky Alexander
CFO
C-Suite Officer 29 496
Value: $29.8K
Jan 22, 2025
Buy
Common Stock
A-Award
Jensen Thomas
CEO
CEO / President 396 734
Value: $400.7K
Sep 30, 2024
Buy
Common Stock
J-Other
Graff Jeremy R.
Officer
Officer 0
Value: $0
Sep 30, 2024
Buy
Common Stock
A-Award
Graff Jeremy R.
See Remarks
Officer 118 483
Value: $250.0K
Sep 30, 2024
Buy
Common Stock
J-Other
Graff Jeremy R.
Officer
Officer 0
Value: $0
Sep 30, 2024
Buy
Common Stock
A-Award
Graff Jeremy R.
See Remarks
Officer 118 483
Value: $250.0K
Sep 12, 2024
Buy
Common Stock
Epshinsky Alexander
Chief Financial Officer
C-Suite Officer 0
Value: $0
Sep 12, 2024
Buy
Common Stock
Epshinsky Alexander
Chief Financial Officer
C-Suite Officer 0
Value: $0
Aug 01, 2023
Buy
Common Stock
J-Other
Benjamin Laura
Director 0
Value: $0
Aug 01, 2023
Buy
Common Stock
J-Other
Benjamin Laura
Director 0
Value: $0
Aug 01, 2023
Buy
Common Stock
J-Other
Vazzano Joseph Walter
Director 0
Value: $0
Aug 01, 2023
Buy
Common Stock
J-Other
Vazzano Joseph Walter
Director 0
Value: $0
Dec 20, 2021
Buy
Stock Options
Carchedi Steve
Chief Executive Officer
CEO / President 70 477
Value: $847.1K
Dec 20, 2021
Buy
Stock Options
Carchedi Steve
Chief Executive Officer
CEO / President 70 477
Value: $847.1K
Dec 20, 2021
Buy
Stock Options
Carchedi Steve
Chief Executive Officer
CEO / President 156 025
Value: $1.36M
Dec 20, 2021
Buy
Stock Options
Carchedi Steve
Chief Executive Officer
CEO / President 252 555
Value: $1.30M
Dec 20, 2021
Buy
Stock Options
Maderis Gail J
Director
Director 400
Value: $3K
Dec 20, 2021
Buy
Stock Options
Maderis Gail J
Director
Director 25 842
Value: $261.3K
Dec 20, 2021
Buy
Stock Options
Maderis Gail J
Director
Director 25 842
Value: $261.3K
Dec 20, 2021
Buy
Stock Options
Maderis Gail J
Director
Director 400
Value: $3K
Dec 20, 2021
Buy
Stock Options
Carchedi Steve
Chief Executive Officer
CEO / President 252 555
Value: $1.30M
Dec 20, 2021
Buy
Stock Options
Carchedi Steve
Chief Executive Officer
CEO / President 156 025
Value: $1.36M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT ALLARITY THERAPEUTICS, INC.
Allarity Therapeutics
Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; Dovitinib, a pan- tyrosine kinase inhibitor for the treatment of renal cell carcinoma; IXEMPRA, a microt...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE